반응형
구분 보고서(영문)
제약/바이오/
임상시험
(2건)		 Cervical Cancer Elimination in the UK Is Within Sight With HPV Vaccine
GLP-1 Receptor Agonist Sales Expected to Reach $125 Billion by 2033
질환별
(9건)		 Plaque Psoriasis: Seven-Market Drug Forecast and Market Analysis – Update
Dengue Transmission Spatial Dynamics in Brazil Investigated in New Study
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis
Arthritis Reduces Nutritional Status in the Elderly Population in Canada
TB Outbreak Spurs Public Health Emergency in California
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast
Bronchiectasis Opportunity Assessment and Forecast 2023-2033
Systemic Lupus Erythematosus: An Epidemiological Examination of Gender Differences
Video Chats Can Enhance Brain Functioning in Socially Isolated Elderly People
컨퍼런스/
심포지엄/
학회/기타
(1건)		 Necessity to Address the Unmet Mental Health Needs of Patients With Chronic Conditions
반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.20. (목)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.3. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.10. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.24. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.12. (금)  (0) 2024.09.15
반응형
구분 보고서 (영문)
제약/바이오/
임상시험
(14건)		 Tymlos Outperforms Teriparatide in Real-World Fracture Analysis
Interim Analysis of APPLAUSE-IgAN Trial Sheds Positive Light on Fabhalta for IgAN
World Immunization Week 2024: mRNA Vaccines Could Reduce Preventable Illness Across Multiple Disease Areas
The Privileged Status of Orphan Medicines in Germany
Key Opinion Leaders on GLP-1 Receptor Agonist Clinical Trial Design
APAC Leads in Clinical Trials for Asthma During 2019–23
AstraZeneca’s Fasenra: Approval for Asthma may initiate COPD Approval
Central Nervous System Remains Most Researched Therapy Area for DCTs
ESCMID Global 2024: Cutting-Edge Vaccines in Development for a Healthier Tomorrow
Jemperli Contends with Blockbuster Keytruda in Endometrial Cancer
FDA Approves Alecensa as Leading-Edge Adjuvant Therapy for ALK-Positive Lung Cancer
ESCMID Global 2024: Drug Resistance in Fungi – a Growing Issue
Insmed’s Brensocatib: A Candidate for Bronchiectasis Treatment, Closer to Approval
ESCMID Global 2024: Advances in Drug Resistance Testing
질환별
(9건)		 Friedreich Ataxia: Competitive Landscape
Post-operative Pain: Competitive Landscape
The Role of CAR-T Cells in Systemic Lupus Erythematosus
ESCMID Global 2024: The Infectious Consequences of Climate Change
ESCMID Global 2024: Highlights on Prophylaxis and Treatment of Infectious Diseases
HER2-Positive Breast Cancer: Epidemiology Forecast to 2033
ESCMID Global 2024: Long-Acting Injectables for HIV Prevention
ESCMID Global 2024: Emerging Bacterial Infections in Neonates and Children
Osteoporosis: Epidemiology Forecast to 2033
컨퍼런스/
심포지엄/
학회/기타
(4건)		 ACC 2024: Arrowhead Pharmaceuticals Presents New Phase II Data at the American College of Cardiology 2024
The Wolbachia Method in the Battle Against Dengue
ACC: EMPACT-MI Study Fails to Meet Primary Endpoint
Extended Time Spent Indoors in School Increases the Risk of Shortsightedness

​

반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.3. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.24. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.24. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.12. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 3.28.(목)  (0) 2024.09.15
반응형
구분 보고서 (영문)
제약/
바이오/
임상시험
(3건)		 FDA Nod Makes Enhertu an Option for Multiple Tumor Indications
New Drug Approvals and Their Contract Manufacture: 2024 Edition
Tymlos Outperforms Teriparatide in Real-World Fracture Analysis
질환별
(8건)		 Cell & Gene Therapies in Rheumatology
Acne Vulgaris: Competitive Landscape
Study Explores the Effects of State Medicaid Policies on Hepatitis C Treatment
Methicillin-Resistant Staphylococcus aureus (MRSA): Epidemiology Forecast to 2033
Changing Epidemiology of Atopic Dermatitis in South Korea
New WHO Hepatitis B Guidelines Address Testing and Treatment Barriers
Syphilis, the Once Near-Eliminated STI, Is Resurging in the US
PPD Affects Races Similarly, Inequities Lie in Mental Healthcare
컨퍼런스/
심포지엄/
학회/기타
(13건)		 ACC 2024: Arrowhead Pharmaceuticals Presents New Phase II Data at the American College of Cardiology 2024
The Wolbachia Method in the Battle Against Dengue
ACC: EMPACT-MI Study Fails to Meet Primary Endpoint
Extended Time Spent Indoors in School Increases the Risk of Shortsightedness
India Sees Insignificant Revision to Price Ceiling in 2024
AAN 2024: Myostatin Inhibitors on the Horizon for the Treatment of SMA
AAN 2024: Amneal Showcases IPX203’s Safety Profile in Anticipation of FDA Approval
AAN 2024: AbbVie Highlights Long-Term Safety of Atogepant in Migraine Prevention
AAN 2024: Biomarker Data Shows Promise for Alzheon’s Oral Anti-Amyloid Drug
AAN 2024: Importance of Early Diagnosis and Prompt Treatment in SMA
AAN 2024: Four-Year Follow-Up of Roche’s PRX-002 Encouraging for Parkinson’s Disease
AAN 2024: New Pooled Data Highlights Efficacy of Axsome Therapeutics’s AXS-07
AAN 2024: Pharma Two B’s P2B001 Shows Promise in Early PD
AAN 2024: Monitoring Adverse Events Associated with Gene Transfer Therapies

 

반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.24. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.10. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.12. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 3.28.(목)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.08.02
반응형

 

구분 보고서 (영문)
 
제약/바이오/
임상시험		 BMS's Breyanzi Sets New Standards as the First CAR T-Cell Therapy for CLL and SLL
CRISPR-Based Assay Could Revolutionize Diagnosis of NTM Infections
Pfizer’s Velsipity UK Approval Raises Competition in the Ulcerative Colitis Market
Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023
Europe Continues to Have the Most Pollen Allergy Clinical Trials
Rare Disease Pipeline Analysis 2023
Oncology Leads Trials for 2023 with More Than 52% of Trials in Phase II
Nanoscope Therapeutics Exhibits Positive Top-Line Phase IIb Results for MCO-010
Antibody-Drug Conjugates (ADC): Market Overview
Rubraca Sheds Positive Light for PARP Inhibitors in Endometrial Cancer
MASH Revival with Over $2.5 Billion for Innovator Drug Partnership Deals in 2024
Lenmeldy Becomes the World’s Most Expensive Drug at a Wholesale Acquisition Cost of $4 million
FDA Nod Makes Enhertu an Option for Multiple Tumor Indications
Surges in Obesity Drugs Forecast to Enter US Market
질환별 After Decades of Waiting, Late-Stage Therapies May Penetrate the COPD Market This Year
Experts Flag Concerns with Drug Compliance in Osteoporosis Landscape
Cell & Gene Therapies in Ophthalmology
Fuchs Endothelial Corneal Dystrophy (FECD):Competitive Landscape
Rheumatoid Arthritis: Competitive Landscape
Peripheral Artery Disease: Competitive Landscape
Retinitis Pigmentosa: Competitive Landscape
Resistant hypertension: Competitive Landscape
컨퍼런스/
심포지엄/
학회/기타		 World Tuberculosis Day 2024: New Vaccines Needed to Tackle Disease Burden
Cheap Drugs, Inspections, and a Future War in Europe – What’s Really Driving Drug Shortages?
CRISPR Drug Licensing Deals Secure $21 Billion in Top 3 Therapy Areas Over 5 Years
The Wolbachia Method in the Battle Against Dengue
반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.10. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.24. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 3.28.(목)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.08.02
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.03.15

+ Recent posts

티스토리툴바